Literature DB >> 30959577

Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress.

Young-Eun Cho1,2, Do-Kyun Kim3, Wonhyo Seo4, Bin Gao4, Seong-Ho Yoo5, Byoung-Joon Song1.   

Abstract

Fructose intake is known to induce obesity, insulin resistance, metabolic syndrome, and nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the effects of fructose drinking on gut leakiness, endotoxemia, and NAFLD and study the underlying mechanisms in rats, mice, and T84 colon cells. Levels of ileum junctional proteins, oxidative stress markers, and apoptosis-related proteins in rodents, T84 colonic cells, and human ileums were determined by immunoblotting, immunoprecipitation, and immunofluorescence analyses. Fructose drinking caused microbiome change, leaky gut, and hepatic inflammation/fibrosis with increased levels of nitroxidative stress marker proteins cytochrome P450-2E1 (CYP2E1), inducible nitric oxide synthase, and nitrated proteins in small intestine and liver of rodents. Fructose drinking significantly elevated plasma bacterial endotoxin levels, likely resulting from decreased levels of intestinal tight junction (TJ) proteins (zonula occludens 1, occludin, claudin-1, and claudin-4), adherent junction (AJ) proteins (β-catenin and E-cadherin), and desmosome plakoglobin, along with α-tubulin, in wild-type rodents, but not in fructose-exposed Cyp2e1-null mice. Consistently, decreased intestinal TJ/AJ proteins and increased hepatic inflammation with fibrosis were observed in autopsied obese people compared to lean individuals. Furthermore, histological and biochemical analyses showed markedly elevated hepatic fibrosis marker proteins in fructose-exposed rats compared to controls. Immunoprecipitation followed by immunoblot analyses revealed that intestinal TJ proteins were nitrated and ubiquitinated, leading to their decreased levels in fructose-exposed rats.
Conclusion: These results showed that fructose intake causes protein nitration of intestinal TJ and AJ proteins, resulting in increased gut leakiness, endotoxemia, and steatohepatitis with liver fibrosis, at least partly, through a CYP2E1-dependent manner.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30959577      PMCID: PMC6783321          DOI: 10.1002/hep.30652

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.298


  45 in total

1.  Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

Authors:  Ina Bergheim; Synia Weber; Miriam Vos; Sigrid Krämer; Valentina Volynets; Seline Kaserouni; Craig J McClain; Stephan C Bischoff
Journal:  J Hepatol       Date:  2008-03-14       Impact factor: 25.083

2.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

Authors:  Lixin Zhu; Susan S Baker; Chelsea Gill; Wensheng Liu; Razan Alkhouri; Robert D Baker; Steven R Gill
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

3.  Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Authors:  Manal F Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; Richard J Johnson; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

4.  Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.

Authors:  Giridhar Kanuri; Astrid Spruss; Sabine Wagnerberger; Stephan C Bischoff; Ina Bergheim
Journal:  J Nutr Biochem       Date:  2010-08-30       Impact factor: 6.048

5.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.

Authors:  M D Weltman; G C Farrell; P Hall; M Ingelman-Sundberg; C Liddle
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

6.  Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury.

Authors:  Young-Eun Cho; Li-Rong Yu; Mohamed A Abdelmegeed; Seong-Ho Yoo; Byoung-Joon Song
Journal:  J Hepatol       Date:  2018-02-16       Impact factor: 25.083

7.  Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

Authors:  Astrid Spruss; Giridhar Kanuri; Sabine Wagnerberger; Synia Haub; Stephan C Bischoff; Ina Bergheim
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

8.  Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.

Authors:  Prasanthi Jegatheesan; Stéphanie Beutheu; Gabrielle Ventura; Esther Nubret; Gilles Sarfati; Ina Bergheim; Jean-Pascal De Bandt
Journal:  J Nutr       Date:  2015-08-05       Impact factor: 4.798

9.  Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.

Authors:  Yuichi Nozaki; Koji Fujita; Koichiro Wada; Masato Yoneda; Takaomi Kessoku; Yoshiyasu Shinohara; Kento Imajo; Yuji Ogawa; Makoto Nakamuta; Satoru Saito; Naohiko Masaki; Yoji Nagashima; Yasuo Terauchi; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2015-04-01       Impact factor: 3.067

Review 10.  Sirtuins and nonalcoholic fatty liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

View more
  30 in total

Review 1.  "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.

Authors:  Mark A Febbraio; Michael Karin
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

2.  Foodborne TiO2 Nanoparticles Induced More Severe Hepatotoxicity in Fructose-Induced Metabolic Syndrome Mice via Exacerbating Oxidative Stress-Mediated Intestinal Barrier Damage.

Authors:  Yu Zhao; Yizhou Tang; Shanji Liu; Tiantian Jia; Donggen Zhou; Hengyi Xu
Journal:  Foods       Date:  2021-04-30

Review 3.  Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases.

Authors:  Winston Hernández-Ceballos; Jacqueline Cordova-Gallardo; Nahum Mendez-Sanchez
Journal:  J Clin Transl Hepatol       Date:  2021-03-08

4.  Fructose Promotion of Intestinal and Liver Injury: A Sugar by Any Other Name That Isn't So Sweet.

Authors:  Lindsey Kennedy; Heather Francis; Gianfranco Alpini
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.298

5.  Sex-Specific Associations of Trimethylamine-N-Oxide and Zonulin with Signs of Depression in Carbohydrate Malabsorbers and Nonmalabsorbers.

Authors:  Sophie Meinitzer; Andreas Baranyi; Sandra Holasek; Wolfgang J Schnedl; Sieglinde Zelzer; Harald Mangge; Markus Herrmann; Andreas Meinitzer; Dietmar Enko
Journal:  Dis Markers       Date:  2020-01-06       Impact factor: 3.434

Review 6.  Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.

Authors:  Haiming Hu; Aizhen Lin; Mingwang Kong; Xiaowei Yao; Mingzhu Yin; Hui Xia; Jun Ma; Hongtao Liu
Journal:  J Gastroenterol       Date:  2019-12-16       Impact factor: 7.527

7.  Ochratoxin A induces liver inflammation: involvement of intestinal microbiota.

Authors:  Wence Wang; Shuangshuang Zhai; Yaoyao Xia; Hao Wang; Dong Ruan; Ting Zhou; Yongwen Zhu; Hongfu Zhang; Minhong Zhang; Hui Ye; Wenkai Ren; Lin Yang
Journal:  Microbiome       Date:  2019-11-28       Impact factor: 14.650

Review 8.  Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Authors:  Hannele Yki-Järvinen; Panu K Luukkonen; Leanne Hodson; J Bernadette Moore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-13       Impact factor: 46.802

Review 9.  Lean NAFLD: an underrecognized and challenging disorder in medicine.

Authors:  Sheila Maier; Amanda Wieland; Melanie Cree-Green; Kristen Nadeau; Shelby Sullivan; Miguel A Lanaspa; Richard J Johnson; Thomas Jensen
Journal:  Rev Endocr Metab Disord       Date:  2021-01-03       Impact factor: 6.514

10.  Antibiotic Treatment Does Not Ameliorate the Metabolic Changes in Rats Presenting Dysbiosis After Consuming a High Fructose Diet.

Authors:  Ariel Bier; Rawan Khasbab; Yael Haberman; Tzipi Braun; Rotem Hadar; Katya Sosnovski; Amnon Amir; Avshalom Leibowitz; Ehud Grossman
Journal:  Nutrients       Date:  2020-01-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.